TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1516995

Group type: EXPERIMENTAL
Intervention: Dialytic ultrafiltration (DUF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Large paracentesis (LP)
Number of subjects: 18
Study: 6367617

Group type: EXPERIMENTAL
Intervention: Estradiol-17 beta 4 mg daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Estradiol-17 beta 2 mg daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Estradiol-17 beta
Number of subjects: 50
Study: 30735912

Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Real driving conditions
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Simulated driving conditions
Number of subjects: 27
Study: 29151382

Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('X Games')
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('snowboard')
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('gym')
Number of subjects: 2040

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Overall exposure to energy drink marketing
Number of subjects: 2040
Study: 26901812

Group type: EXPERIMENTAL
Intervention: Testosterone gel (0, 1.25, 2.5, 5, or 10 grams daily for 16 weeks)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Testosterone gel with anastrozole (suppressing conversion of androgens to estrogens)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo for goserelin and testosterone
Number of subjects: 198
Study: 25281437

Group type: EXPERIMENTAL
Intervention: Colloid preload (6% hydroxyethyl starch 130/0.4 500 mL before spinal anesthesia)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Crystalloid co-load (Ringer's acetate solution 1000 mL administered rapidly starting with intrathecal injection)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Colloid preload
Number of subjects: 210

Group type: COMPARATOR
Intervention: Crystalloid co-load
Number of subjects: 210
Study: 22458343

Group type: EXPERIMENTAL
Intervention: Epidural steroid injections with local anesthetic
Number of subjects: 400

Group type: COMPARATOR
Intervention: Epidural injections with local anesthetic alone (Control)
Number of subjects: 400
Study: 20147463

Group type: EXPERIMENTAL
Intervention: Fiber-enriched meal (psyllium, 23.0 g)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High protein and fiber meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low protein and fiber meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low protein and high soluble fiber meal
Number of subjects: 16
Study: 17700298

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nontreatment comparison group
Number of subjects: 20
Study: 16075898

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: High-carbohydrate diet (Control)
Number of subjects: 31
Study: 12126546

Group type: EXPERIMENTAL
Intervention: Epidural 2% lidocaine 10 ml combined with 2.5 microg/ml of fentanyl 30 minutes before skin incision followed by 0.125% ropivacaine and 2 microg/ml fentanyl infusion at 9ml/h to the end of surgery (Group II)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Epidural 2% lidocaine 10 ml combined with 2.5 microg/ml of fentanyl and 0.15 mg/ml of droperidol 30 min before incision followed by 0.125% ropivacaine and 2 microg/ml fentanyl infusion at 9ml/h to the end of surgery (Group III)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Epidural saline as control (Group I)
Number of subjects: 75
Study: 10410825

Group type: EXPERIMENTAL
Intervention: 1 mg of propranolol administered IC into the treated artery during balloon inflations
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1 mg IC propranolol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 15
Study: 7812229

Group type: EXPERIMENTAL
Intervention: Conservative therapeutic schemes
Number of subjects: 195
Study: 2840293

Group type: EXPERIMENTAL
Intervention: Intra-arterial ketanserin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31081793

Group type: EXPERIMENTAL
Intervention: Gocovri (amantadine)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 30514358

Group type: EXPERIMENTAL
Intervention: Dual-acupoint TEAS
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Single-acupoint TEAS
Number of subjects: 345

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 345
Study: 28027638

Group type: EXPERIMENTAL
Intervention: Completely enriched milk powder
Number of subjects: 104

Group type: COMPARATOR
Intervention: Iron- and vitamin folic-acid-enriched milk powder
Number of subjects: 104
Study: 25056567

Group type: EXPERIMENTAL
Intervention: Extended-release dexmethylphenidate (d-MPH)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Extended-release mixed amphetamine salts (MAS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 22268365

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Irbesartan 600 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Irbesartan 900 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Irbesartan (high u-KIM1 patients)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 52
Study: 19933235

Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg/day for five consecutive days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Meloxicam 30 mg/day for five consecutive days
Number of subjects: 27
Study: 17681986

Group type: EXPERIMENTAL
Intervention: Standard bowel purgation (Group 1)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Fasting (Group 2)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No preparation (Group 3)
Number of subjects: 210
Study: 15539438

Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 1030

Group type: COMPARATOR
Intervention: COC
Number of subjects: 1030
Study: 11999639

Group type: EXPERIMENTAL
Intervention: pimobendan (1.25 or 2.5mg twice daily)
Number of subjects: 306
Study: 9818595

Group type: EXPERIMENTAL
Intervention: Combined interrupted and continuous suturing (ICS)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Single continuous adjustable suturing (SCAS)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study: 7815048

Group type: EXPERIMENTAL
Intervention: Happy mood induction
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Neutral mood induction
Number of subjects: 182
Study: 2511939

Group type: EXPERIMENTAL
Intervention: Non-attenders
Number of subjects: 247
Study: 1959

Group type: EXPERIMENTAL
Intervention: Mequitazine (10 mg/24 hrs)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Mequitazine
Number of subjects: 115
Study: 7313613

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 200 ppm Methyl Chloride (MeCl)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of Diazepam and 200 ppm MeCl
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 30782795

Group type: EXPERIMENTAL
Intervention: Citizen science trials with crowdsourced data from farmers ranking the performance of three varieties.
Number of subjects: 12409

Group type: COMPARATOR
Intervention: Previous variety recommendations.
Number of subjects: 12409
Study: 27516073

Group type: EXPERIMENTAL
Intervention: Stimulant dependence
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Alcohol dependence
Number of subjects: 131
Study: 25603757

Group type: EXPERIMENTAL
Intervention: Augmented Feedback (AF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional exercises (PT group)
Number of subjects: 20
Study: 24457404

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg bid for 6 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg qd for 6 months
Number of subjects: 73

Group type: COMPARATOR
Intervention: Orlistat 120 mg tid for 6 months
Number of subjects: 73
Study: 20880335

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel, 80 mg/m², for 12 cycles (B1) when sensitivity test positive
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control arm (A): Weekly paclitaxel without sensitivity test
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: FEC100 for 4 cycles (B2) when sensitivity test negative
Number of subjects: 92
Study: 19302634

Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in Group 70 (70 beats/min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in Group 90 (90 beats/min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in both groups
Number of subjects: 40
Study: 17917525

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 3
Study: 15555694

Group type: EXPERIMENTAL
Intervention: Family therapy plus pharmacotherapy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Multifamily psychoeducational group therapy plus pharmacotherapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Pharmacotherapy alone
Number of subjects: 92
Study: 11458297

Group type: EXPERIMENTAL
Intervention: Anterior transposition of the inferior oblique muscle (ATIO)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Disinsertion of the inferior oblique muscle (DIO)
Number of subjects: 22
Study: 9894374

Group type: EXPERIMENTAL
Intervention: Felodipine ER 2.5 mg (increased to 5 mg or 10 mg if necessary)
Number of subjects: 535

Group type: COMPARATOR
Intervention: Amlodipine 5 mg (increased to 10 mg if necessary)
Number of subjects: 535
Study: 7811559

Group type: EXPERIMENTAL
Intervention: 123I‐MIBG imaging
Number of subjects: 23

Group type: COMPARATOR
Intervention: 123I‐BMIPP imaging
Number of subjects: 23

Group type: COMPARATOR
Intervention: Echocardiography (%SF)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Echocardiography (E/A ratio)
Number of subjects: 23
Study: 3138303

Group type: EXPERIMENTAL
Intervention: Enprostil (35 micrograms twice daily)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 313
Study: 30791873

Group type: EXPERIMENTAL
Intervention: Clamping after at least 2 min
Number of subjects: 261

Group type: COMPARATOR
Intervention: Clamping within 20 s
Number of subjects: 261
Study: 28820439

Group type: EXPERIMENTAL
Intervention: Letibotulinum toxin A (Botulax)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Onabotulinum toxin A (Botox)
Number of subjects: 144
Study: 26255474

Group type: EXPERIMENTAL
Intervention: Treatment group (salmon calcitonin added to calcium and calcitriol)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Comprehensive group (incrementality waist musculi dorsi function exercise added to treatment group)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (calcium and calcitriol)
Number of subjects: 138
Study: 23297680

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02(D) vaccine
Number of subjects: 340

Group type: COMPARATOR
Intervention: Hepatitis B vaccine (Control)
Number of subjects: 340
Study: 21872139

Group type: EXPERIMENTAL
Intervention: CCM (Cardiac Contractility Modulation)
Number of subjects: 428

Group type: COMPARATOR
Intervention: OMT (Optimal Medical Treatment)
Number of subjects: 428
Study: 19465671

Group type: EXPERIMENTAL
Intervention: Progestelle progesterone cream 20 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Progestelle progesterone cream 60 mg, 40 mg, 5 mg
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 16616450

Group type: EXPERIMENTAL
Intervention: Buddy condition (n=237)
Number of subjects: 563

Group type: COMPARATOR
Intervention: Control condition (n=326)
Number of subjects: 563
Study: 15275942

Group type: EXPERIMENTAL
Intervention: Inhalations of 20% carbon dioxide (CO2)‐enriched air
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Unmasked and masked attentional bias indices
Number of subjects: 87
Study: 10431474

Group type: EXPERIMENTAL
Intervention: Sublingual administration of flash liberation tablet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sublingual administration of freeze-dried reference tablet (lyoc)
Number of subjects: 12
Study: 8755841

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients after lower limb amputation
Number of subjects: 246

Group type: COMPARATOR
Intervention: Normal glucose tolerance patients after lower limb amputation
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients
Number of subjects: 246

Group type: COMPARATOR
Intervention: Normal glucose tolerance patients
Number of subjects: 246
Study: 1862205

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0
Study: 6553504

Group type: EXPERIMENTAL
Intervention: IV infusions of gamma‐radiation‐sterilized cells of Propionibacterium granulosum strain KP‐45
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cytostatic drugs only (adriamycin, cyclophosphamide, and 5‐fluorouracil)
Number of subjects: 82
Study: 31081899

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 160

Group type: COMPARATOR
Intervention: Both Acupuncture and CBT-I
Number of subjects: 160
Study: 30192807

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 147

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 147
Study: 26817506

Group type: EXPERIMENTAL
Intervention: Higher-protein diet (2.4 g · kg(‐1) · d(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lower-protein diet (1.2 g · kg(‐1) · d(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (PRO and CON)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Changes in serum cortisol
Number of subjects: 40
Study: 24629431

Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 6.3mg/kg (1×)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 18.9 mg/kg (3×)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 31.5mg/kg (5×)
Number of subjects: 32

Group type: COMPARATOR
Intervention: non‐treated control
Number of subjects: 32
Study: 22564336

Group type: EXPERIMENTAL
Intervention: Group A (awareness of rhinomanometry scores)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group B (unaware of rhinomanometry scores)
Number of subjects: 60
Study: 20925931

Group type: EXPERIMENTAL
Intervention: Physical activity intervention after 12 months follow-up
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Successful aging health education intervention after 12 months follow-up
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Abbreviated version of the LLDI
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Personal subscale of the LLDI
Number of subjects: 424
Study: 19079397

Group type: EXPERIMENTAL
Intervention: Microscope
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Loupe
Number of subjects: 251
Study: 15959421

Group type: EXPERIMENTAL
Intervention: Non-mydriatic camera
Number of subjects: 784

Group type: COMPARATOR
Intervention: Dilated eye examination
Number of subjects: 784
Study: 12919776

Group type: EXPERIMENTAL
Intervention: TNK/ABCX
Number of subjects: 4304

Group type: EXPERIMENTAL
Intervention: TNK/ENOX
Number of subjects: 4304

Group type: COMPARATOR
Intervention: TNK/UH
Number of subjects: 4304
Study: 10566718

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g i.v. 30 min preintervention
Number of subjects: 141

Group type: COMPARATOR
Intervention: No study medication (control)
Number of subjects: 141
Study: 8738816

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 108
Study: 1681847

Group type: EXPERIMENTAL
Intervention: ICI‐118551
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol and Propranolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 8
Study: 7049585

Group type: EXPERIMENTAL
Intervention: Meptazinol (400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dextropropoxyphene (65 mg) plus Paracetamol (650 mg)
Number of subjects: 0
Study: 30743211

Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 1804

Group type: EXPERIMENTAL
Intervention: Femoral access (FA) by default radial operators
Number of subjects: 1804

Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 1804
Study: 27762602

Group type: EXPERIMENTAL
Intervention: Forsus
Number of subjects: 28

Group type: COMPARATOR
Intervention: Elastics
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 26980844

Group type: EXPERIMENTAL
Intervention: Measured tensioning device (80 N)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Physician group (conventional tensioning)
Number of subjects: 113
Study: 25196020

Group type: EXPERIMENTAL
Intervention: Moxifloxacin replacing ethambutol for 17 weeks followed by 9 weeks of placebo (isoniazid group)
Number of subjects: 1931

Group type: EXPERIMENTAL
Intervention: Moxifloxacin replacing isoniazid for 17 weeks followed by 9 weeks of placebo (ethambutol group)
Number of subjects: 1931

Group type: COMPARATOR
Intervention: Control regimen: isoniazid, rifampin, pyrazinamide, and ethambutol for 8 weeks, followed by 18 weeks of isoniazid and rifampin
Number of subjects: 1931

Group type: COMPARATOR
Intervention: Control group (for hazard ratios)
Number of subjects: 1931

Group type: EXPERIMENTAL
Intervention: All groups (isoniazid, ethambutol, control)
Number of subjects: 1931
Study: 22467013

Group type: EXPERIMENTAL
Intervention: Chemotherapy (cytostatic and genotoxic drugs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (nonsmoker women)
Number of subjects: 25
Study: 20575089

Group type: EXPERIMENTAL
Intervention: Segregated clinic (PA-free)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Mixed clinic (PA-positive)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: New clinic with proper hygiene precautions
Number of subjects: 39

Group type: COMPARATOR
Intervention: Old site (mixed clinic)
Number of subjects: 39
Study: 17610321

Group type: EXPERIMENTAL
Intervention: 8-week group-education program for RA
Number of subjects: 208

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 208
Study: 16116005

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (2.2 mL of 0.5% hyperbaric bupivacaine plus 0.2 mg morphine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epidural anesthesia (2% lidocaine with epinephrine 1:400,000, 18‐23 mL, followed by 3 mg of morphine after delivery)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Neonatal outcomes (assessed by Apgar scores and umbilical arterial blood gas analysis)
Number of subjects: 100
Study: 11823107

Group type: EXPERIMENTAL
Intervention: Localization-related epilepsy (LRE) with interictal psychosis
Number of subjects: 653

Group type: COMPARATOR
Intervention: Localization-related epilepsy (LRE)
Number of subjects: 653
Study: 10027033

Group type: EXPERIMENTAL
Intervention: (R)-ketamine 1 mg/kg (PRE group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (PLA group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saline followed by (R)-ketamine 1 mg/kg (POST group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meperidine consumption (all groups)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Analgesic consumption at 24 h and 7 days (all groups)
Number of subjects: 60
Study: 1492006

Group type: EXPERIMENTAL
Intervention: ciprofloxacin 500 mg twice/day for 10 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo twice/day for 10 days
Number of subjects: 16
Study: 3714290

Group type: EXPERIMENTAL
Intervention: Arm ergometer training programme (30 min per day, 5 days per week, for 8 consecutive weeks at 80% of peak heart rate, 50 rev/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Arm ergometer training programme
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study: 28968870

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg once daily for 4 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg once daily for 4 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of both drugs
Number of subjects: 120
Study: 27188698

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 20000

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20000
Study: 25470442

Group type: EXPERIMENTAL
Intervention: Long-term temporal framing for at-risk nonsmokers
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Short-term temporal framing for at-risk nonsmokers
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Short-term temporal framing for smokers
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Low-CFC smokers
Number of subjects: 395
Study: 23397303

Group type: EXPERIMENTAL
Intervention: Actigraph GT3X
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: DynaPort MoveMonitor
Number of subjects: 80
Study: 21244215

Group type: EXPERIMENTAL
Intervention: 0.25% DHEA
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 0.5% DHEA
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 1.0% DHEA
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 18451734

Group type: EXPERIMENTAL
Intervention: Fimbrolide-coated lenses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Uncoated contact lenses
Number of subjects: 10
Study: 16737407

Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Nonpharmacological interventions
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All studies combined
Number of subjects: 81
Study: 15248440

Group type: EXPERIMENTAL
Intervention: Acetylcysteine (600 mg in the morning and evening before examination) with intravenous saline hydration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (hydration alone)
Number of subjects: 120